{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["Apoptosis", "and", "growth", "inhibition", "in", "malignant", "lymphocytes", "after", "treatment", "with", "arsenic", "trioxide", "at", "clinically", "achievable", "concentrations", "[", "see", "comments", "]"], "sentence": "Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations [ see comments ]", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["BACKGROUND", ":", "Arsenic", "trioxide", "(", "As2O3", ")", "can", "induce", "clinical", "remission", "in", "patients", "with", "acute", "promyelocytic", "leukemia", "via", "induction", "of", "differentiation", "and", "programmed", "cell", "death", "(", "apoptosis", ")", "."], "sentence": "BACKGROUND : Arsenic trioxide ( As2O3 ) can induce clinical remission in patients with acute promyelocytic leukemia via induction of differentiation and programmed cell death ( apoptosis ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["We", "investigated", "the", "effects", "of", "As2O3", "on", "a", "panel", "of", "malignant", "lymphocytes", "to", "determine", "whether", "growth", "-", "inhibitory", "and", "apoptotic", "effects", "of", "As2O3", "can", "be", "observed", "in", "these", "cells", "at", "clinically", "achievable", "concentrations", "."], "sentence": "We investigated the effects of As2O3 on a panel of malignant lymphocytes to determine whether growth - inhibitory and apoptotic effects of As2O3 can be observed in these cells at clinically achievable concentrations .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["METHODS", ":", "Eight", "malignant", "lymphocytic", "cell", "lines", "and", "primary", "cultures", "of", "lymphocytic", "leukemia", "and", "lymphoma", "cells", "were", "treated", "with", "As2O3", ",", "with", "or", "without", "dithiothreitol", "(", "DTT", ")", "or", "buthionine", "sulfoximine", "(", "BSO", ")", "(", "an", "inhibitor", "of", "glutathione", "synthesis", ")", "."], "sentence": "METHODS : Eight malignant lymphocytic cell lines and primary cultures of lymphocytic leukemia and lymphoma cells were treated with As2O3 , with or without dithiothreitol ( DTT ) or buthionine sulfoximine ( BSO ) ( an inhibitor of glutathione synthesis ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "S5", "tokens": ["Apoptosis", "was", "assessed", "by", "cell", "morphology", ",", "flow", "cytometry", ",", "annexin", "V", "protein", "level", ",", "and", "terminal", "deoxynucleotidyl", "transferase", "labeling", "of", "DNA", "fragments", "."], "sentence": "Apoptosis was assessed by cell morphology , flow cytometry , annexin V protein level , and terminal deoxynucleotidyl transferase labeling of DNA fragments .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "annexin V", "entity_type": "Protein", "start": 10, "end": 11}, {"id": "T2", "text": "terminal deoxynucleotidyl transferase", "entity_type": "Protein", "start": 16, "end": 18}]}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["Cellular", "proliferation", "was", "determined", "by", "5-bromo-2'-deoxyuridine", "incorporation", "into", "DNA", "and", "flow", "cytometry", "and", "by", "use", "of", "a", "mitotic", "arrest", "assay", "."], "sentence": "Cellular proliferation was determined by 5-bromo-2'-deoxyuridine incorporation into DNA and flow cytometry and by use of a mitotic arrest assay .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["Mitochondrial", "transmembrane", "potential", "(", "delta", "psi", "(", "m", ")", ")", "was", "measured", "by", "means", "of", "rhodamine", "123", "staining", "and", "flow", "cytometry", "."], "sentence": "Mitochondrial transmembrane potential ( delta psi ( m ) ) was measured by means of rhodamine 123 staining and flow cytometry .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["Protein", "expression", "was", "assessed", "by", "western", "blot", "analysis", "or", "immunofluorescence", "."], "sentence": "Protein expression was assessed by western blot analysis or immunofluorescence .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["RESULTS", ":", "Therapeutic", "concentrations", "of", "As2O3", "(", "1-2", "microM", ")", "had", "dual", "effects", "on", "malignant", "lymphocytes", ":", "1", ")", "inhibition", "of", "growth", "through", "adenosine", "triphosphate", "(", "ATP", ")", "depletion", "and", "prolongation", "of", "cell", "cycle", "time", "and", "2", ")", "induction", "of", "apoptosis", "."], "sentence": "RESULTS : Therapeutic concentrations of As2O3 ( 1-2 microM ) had dual effects on malignant lymphocytes : 1 ) inhibition of growth through adenosine triphosphate ( ATP ) depletion and prolongation of cell cycle time and 2 ) induction of apoptosis .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["As2O3", "-", "induced", "apoptosis", "was", "preceded", "by", "delta", "psi", "(", "m", ")", "collapse", "."], "sentence": "As2O3 - induced apoptosis was preceded by delta psi ( m ) collapse .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["DTT", "antagonized", "and", "BSO", "enhanced", "As2O3", "-", "induced", "ATP", "depletion", ",", "delta", "psi", "(", "m", ")", "collapse", ",", "and", "apoptosis", "."], "sentence": "DTT antagonized and BSO enhanced As2O3 - induced ATP depletion , delta psi ( m ) collapse , and apoptosis .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "S12", "tokens": ["Caspase-3", "activation", ",", "usually", "resulting", "from", "delta", "psi", "(", "m", ")", "collapse", ",", "was", "not", "always", "associated", "with", "As2O3", "-", "induced", "apoptosis", "."], "sentence": "Caspase-3 activation , usually resulting from delta psi ( m ) collapse , was not always associated with As2O3 - induced apoptosis .", "event_mentions": [], "entity_mentions": [{"id": "T3", "text": "Caspase-3", "entity_type": "Protein", "start": 0, "end": 0}]}
{"doc_id": "PMID-10328107.txt", "sent_id": "S13", "tokens": ["As2O3", "induced", "PML", "(", "promyelocytic", "leukemia", ")", "protein", "degradation", "but", "did", "not", "modulate", "expression", "of", "cell", "cycle-related", "proteins", ",", "including", "c-myc", ",", "retinoblastoma", "protein", ",", "cyclin-dependent", "kinase", "4", ",", "cyclin", "D1", ",", "and", "p53", ",", "or", "expression", "of", "differentiation-related", "antigens", "."], "sentence": "As2O3 induced PML ( promyelocytic leukemia ) protein degradation but did not modulate expression of cell cycle-related proteins , including c-myc , retinoblastoma protein , cyclin-dependent kinase 4 , cyclin D1 , and p53 , or expression of differentiation-related antigens .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "PML", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T5", "text": "c-myc", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T6", "text": "retinoblastoma protein", "entity_type": "Protein", "start": 22, "end": 23}, {"id": "T7", "text": "cyclin-dependent kinase 4", "entity_type": "Protein", "start": 25, "end": 27}, {"id": "T8", "text": "cyclin D1", "entity_type": "Protein", "start": 29, "end": 30}, {"id": "T9", "text": "p53", "entity_type": "Protein", "start": 33, "end": 33}]}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["CONCLUSIONS", ":", "Substantial", "growth", "inhibition", "and", "apoptosis", "without", "evidence", "of", "differentiation", "were", "induced", "in", "most", "malignant", "lymphocytic", "cells", "treated", "with", "1-2", "microM", "As2O3", "."], "sentence": "CONCLUSIONS : Substantial growth inhibition and apoptosis without evidence of differentiation were induced in most malignant lymphocytic cells treated with 1-2 microM As2O3 .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10328107.txt", "sent_id": "", "tokens": ["As2O3", "may", "prove", "useful", "in", "the", "treatment", "of", "malignant", "lymphoproliferative", "disorders", "."], "sentence": "As2O3 may prove useful in the treatment of malignant lymphoproliferative disorders .", "event_mentions": [], "entity_mentions": []}
